APPEARANCE OF EXTRAPYRAMIDAL SYMPTOMS - INTERACTION BETWEEN NEUROLEPTICS AND OTHER CNS ACTIVE-DRUGS

被引:4
作者
FREGNAN, GB
VIDALI, M
机构
关键词
D O I
10.1159/000137730
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:102 / 110
页数:9
相关论文
共 22 条
[1]   STUDIES ON BIOSYNTHESIS AND LOCALIZATION OF HISTAMINE IN DEVELOPING RAT-BRAIN [J].
BAUDRY, M ;
MARTRES, MP ;
SCHWARTZ, JC .
AGENTS AND ACTIONS, 1974, 4 (03) :182-182
[2]   RELATIVE ROLE OF BRAIN ACETYLCHOLINE AND HISTAMINE IN PERPHENAZINE CATATONIA AND INFLUENCE OF ANTIDEPRESSANTS AND DIPHENHYDRAMINE ALONE AND IN COMBINATION [J].
CHOPRA, YM ;
DANDIYA, PC .
NEUROPHARMACOLOGY, 1975, 14 (08) :555-560
[3]   MECHANISM OF POTENTIATING EFFECT OF ANTIDEPRESSANT DRUGS ON PROTECTIVE INFLUENCE OF DIPHENHYDRAMINE IN EXPERIMENTAL CATATONIA - ROLE OF HISTAMINE [J].
CHOPRA, YM ;
DANDIYA, PC .
PHARMACOLOGY, 1974, 12 (06) :347-353
[4]   A NOTE ON A SIMPLE APPARATUS FOR DETECTING NEUROLOGICAL DEFICIT IN RATS AND MICE [J].
DUNHAM, NW ;
MIYA, TS .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (03) :208-209
[5]   PHARMACOLOGICAL PROFILE OF A NEW PSYCHOTHERAPEUTIC AGENT - 4-PARA-FLUOROPHENYL-5-N(N'-O-METHOXYPHENYL)PIPERAZINOETHYL-4-OXAZOLIN-2-ONE (LR511) [J].
FREGNAN, GB ;
VIDALI, M .
PHARMACOLOGY, 1977, 15 (06) :485-502
[6]  
GARBARG M, 1974, AGENTS ACTIONS, V4, P181, DOI 10.1007/BF01970260
[7]   HISTAMINERGIC PATHWAY IN RAT-BRAIN EVIDENCED BY LESIONS OF MEDIAL FOREBRAIN-BUNDLE [J].
GARBARG, M ;
BARBIN, G ;
FEGER, J ;
SCHWARTZ, JC .
SCIENCE, 1974, 186 (4166) :833-835
[8]   ROLE OF 5-HT IN ACTION OF SOME DRUGS AFFECTING EXTRAPYRAMIDAL SYSTEM [J].
GUMULKA, W ;
KOSTOWSKI, W ;
CZLONKOWSKI, A .
PHARMACOLOGY, 1973, 10 (06) :363-372
[9]   HISTAMINE H2-RECEPTORS ON SINGLE CENTRAL NEURONS [J].
HAAS, HL ;
BUCHER, UM .
NATURE, 1975, 255 (5510) :634-635
[10]   REDUCED CATALEPTOGENIC EFFECTS OF SOME NEUROLEPTICS IN RATS WITH LESIONED MIDBRAIN RAPHE AND TREATED WITH PARA-CHLOROPHENYLALANINE [J].
KOSTOWSKI, W ;
GUMULKA, W ;
CZLONKOWSKI, A .
BRAIN RESEARCH, 1972, 48 (DEC24) :443-446